Biotech news
Pharma
Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire. 31 October 2018
Americas
With several major drugs set to face generic or biosimilar competition as patent protection expires, LSIPR analyses how well prepared their manufacturers are and how badly their sales may be affected. 26 October 2018
Americas
Siew Yen Chong has joined Nelson Mullins Riley & Scarborough’s New York office as of counsel. 26 October 2018
Americas
Duane Morris has appointed Patrick Gallagher as chair of the firm’s pharmaceuticals and biopharmaceuticals litigation and regulatory practice group. 25 October 2018
Americas
The implementation of precision medicine represents a huge, possibly unprecedented, challenge to conventional clinical practice across the breadth of healthcare disciplines, says Daniel Lim of Kirkland & Ellis. 23 October 2018
Americas
Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants. 23 October 2018
Biotech
An EU court ruling on gene-editing regulation has sparked widespread concerns in the scientific and legal communities, as LSIPR finds out. 22 October 2018
Americas
Novartis is planning to acquire Endocyte, an Indiana-based biotech, to accelerate its development of radiopharmaceuticals. 22 October 2018
Americas
AbbVie has announced that it has entered into a licensing deal with Germany-based pharmaceutical company Fresenius Kabi. 22 October 2018
Americas
The US Food and Drug Administration has allowed the first US-based human trial of CRISPR, the gene-editing technology, to proceed. 17 October 2018